Lanthiopep B.V.
Records under this name other than patents Lanthiopep B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Lanthiopep B.V.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,835,375 | Cyclic Angiotensin Analogs Lapsed on the fee record Ended Sep 16, 2026 · High confidence | Lapsed on the fee record | Ended Sep 16, 2026 | High confidence |
| US 9,707,268 | Angiotensin type 2 (AT2) receptor agonists and uses thereof Lapsed on the fee record Ended Jul 18, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 18, 2025 | From the USPTO record |
| US 9,651,558 | Bacterial surface display and screening of thioether-bridge-containing peptides Lapsed on the fee record Ended May 16, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 16, 2025 | From the USPTO record |
| US 10,774,323 | Methods for displaying cyclic peptides on bacteriophage particles Lapsed on the fee record Ended Sep 15, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 15, 2024 | From the USPTO record |
| US 9,290,540 | Angiotensin Type 2 (AT2) receptor agonists and uses thereof Lapsed on the fee record Ended Mar 22, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 22, 2024 | From the USPTO record |
| US 10,501,514 | Cyclic galanin-analogs and uses thereof Lapsed on the fee record Ended Dec 10, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 10, 2023 | From the USPTO record |
| US 10,214,563 | Angiotensin type 2 (AT2) receptor agonists and uses thereof Lapsed on the fee record Ended Feb 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended Feb 26, 2023 | From the USPTO record |
| US 6,861,236 | Export and modification of (poly)peptides in the lantibiotic way Term ended Term ended Feb 7, 2023 · From the USPTO record | Term ended | Term ended Feb 7, 2023 | From the USPTO record |
| US 8,835,616 | Methods for the production and secretion of modified peptides Lapsed on the fee record Ended Sep 16, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 16, 2022 | From the USPTO record |